[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @TLwpstkatlqaks ExplosiveRise ExplosiveRise posts on X about strong, microsoft, short interest, ipo the most. They currently have XX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1958202390999695360/interactions)  - X Week XXX +71% - X Month XXXXX +208% ### Mentions: XX [#](/creator/twitter::1958202390999695360/posts_active)  - X Week XX +9.70% - X Month XX +8.50% ### Followers: XX [#](/creator/twitter::1958202390999695360/followers)  - X Week XX +7.10% - X Month XX +36% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1958202390999695360/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) [stocks](/list/stocks) [technology brands](/list/technology-brands) [currencies](/list/currencies) [countries](/list/countries) [travel destinations](/list/travel-destinations) **Social topic influence** [strong](/topic/strong), [microsoft](/topic/microsoft) #2205, [short interest](/topic/short-interest) #48, [ipo](/topic/ipo) #784, [ai](/topic/ai), [products](/topic/products), [ceo](/topic/ceo), [future](/topic/future), [realtime](/topic/realtime), [accounting](/topic/accounting) **Top assets mentioned** [Microsoft Corp. (MSFT)](/topic/microsoft) ### Top Social Posts Top posts by engagements in the last XX hours "#Seegene posted strong Q3 results with KRW 1135B in revenue and KRW 146B net profit driven by reagent sales and cost efficiency. Non-respiratory products grew steadily and global expansion plus new platforms like #STAgora and #CURECA mark a strategic turning point" [X Link](https://x.com/TLwpstkatlqaks/status/1987166670486688086) 2025-11-08T14:33Z XX followers, XX engagements "#Seegene partners with #Microsoft to build a PCR tech-sharing platform using #Azure AI and HPC achieving XX% workforce efficiency and 20x faster analysis. With Microsoft Fabric they aim to expand global collaboration and accelerate innovation across diagnostics" [X Link](https://x.com/TLwpstkatlqaks/status/1987685587172888824) 2025-11-10T00:55Z XX followers, XX engagements "#Seegene unveiled #CURECA and #STAgora at LMCE 2025. STAgora aids clinical decisions via real-time PCR data analytics while CURECA automates PCR testing to boost lab efficiency and accuracy" [X Link](https://x.com/TLwpstkatlqaks/status/1987704155860021723) 2025-11-10T02:09Z XX followers, XX engagements "Chun Jong-yoon founder of #Seegene blends science and entrepreneurship with global vision and ethical leadership. His company advances molecular diagnostics into daily life expanding globally with AI-driven platforms and pandemic-ready solutions" [X Link](https://x.com/TLwpstkatlqaks/status/1987744863585194302) 2025-11-10T04:51Z XX followers, XX engagements "#Seegene led by CEO Chun Jong-yoon aims for a disease-free world through PCR-based diagnostics. By combining #AI #cloud #automation and global tech-sharing it evolves into a #platform firm enabling rapid accurate and accessible testing worldwide" [X Link](https://x.com/TLwpstkatlqaks/status/1987777974230516084) 2025-11-10T07:02Z XX followers, XX engagements "#Seegene reduced COVID-19 reliance achieving XX% YoY growth in Q3 2025. Non-COVID non-respiratory diagnostics now lead its portfolio. With AI automation and global expansion success in North America is vital for sustained growth" [X Link](https://x.com/TLwpstkatlqaks/status/1988035256616890848) 2025-11-11T00:05Z XX followers, XX engagements "#Seegene Medical Foundation opened its new 35th anniversary headquarters in Seoul featuring the worlds first fully automated PCR platform advanced labs and AI systems. The tower symbolizes Seegenes global vision to lead future diagnostics and healthcare innovation" [X Link](https://x.com/TLwpstkatlqaks/status/1988042619134595440) 2025-11-11T00:34Z XX followers, XX engagements "#Seegene and partners developed a rapid multiplex PCR test to detect Asian-type DEL a rare blood variant often misclassified as RhD-negative. With XXX% accuracy and faster results it enhances transfusion safety and has gained global recognition in molecular diagnostics" [X Link](https://x.com/TLwpstkatlqaks/status/1988044217365700850) 2025-11-11T00:40Z XX followers, XX engagements "#Seegene & #Microsoft formed a strategic alliance to build global diagnostic ecosystem. By integrating AI and cloud technologiesthey unveiled #CURECA& #STAgora revolutionizing PCR automation and realtime analysis. is evolving into platform company driving faster diagnostics" [X Link](https://x.com/TLwpstkatlqaks/status/1988052341631971852) 2025-11-11T01:13Z XX followers, XX engagements "#Seegene partners with #Microsoft and #SpringerNature to globalize its PCR tech via AI-driven automation aiming for a disease-free world and transforming biotech through open innovation and global collaboration" [X Link](https://x.com/TLwpstkatlqaks/status/1988061677305442357) 2025-11-11T01:50Z XX followers, XX engagements "#Seegene is evolving into a platform company by sharing its automated diagnostic system globally. Through strategic partnerships with Microsoft and Springer Nature it advances AI-driven automation and fosters open innovation to develop localized diagnostic solutions" [X Link](https://x.com/TLwpstkatlqaks/status/1988064913957474324) 2025-11-11T02:03Z XX followers, XX engagements "#Seegene holds 198.6B in treasury shares XXXX% of total stock as strategic assets for M&A and tech-sharing. While this signals proactive investment exceeding XX% may raise concerns among shareholders highlighting the need for transparent utilization plans" [X Link](https://x.com/TLwpstkatlqaks/status/1988069521840812441) 2025-11-11T02:21Z XX followers, XX engagements "#Seegene is a global leader in molecular diagnostics pioneering syndromic quantitative PCR technology and AI-driven automation. With strategic partnerships like #Microsoft and #SpringerNature Seegene empowers early accurate disease detection worldwide driving innovation" [X Link](https://x.com/TLwpstkatlqaks/status/1988086218576593268) 2025-11-11T03:27Z XX followers, XX engagements "As of November X 2025 #Seegene has a total of 52226000 shares outstanding. The net short-selling balance stands at 122208 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1988221862334394400) 2025-11-11T12:26Z XX followers, XX engagements "#Seegene posted Q3 revenue of KRW 113.5B and operating profit of KRW 9.6B up XXXXX% QoQ. Net profit surged to KRW 14.6B. Diagnostic reagents drove XXXX% of sales with strong growth in non-respiratory products. Cost efficiency and product mix boosted profitability" [X Link](https://x.com/TLwpstkatlqaks/status/1988397365003444656) 2025-11-12T00:04Z XX followers, XX engagements "As of Nov XX 2025 #Seegene is undervalued at KRW 25500 (EV/EBITDA 7x vs global avg 13x). H1 liquid assets rose to KRW 763.1B cash to KRW 268.8B. Non-current liabilities fell by KRW 5.6B. Retained earnings hit KRW 1.073T showing strong financial stability" [X Link](https://x.com/TLwpstkatlqaks/status/1988401459323695511) 2025-11-12T00:20Z XX followers, XX engagements "#Seegene Investment Highlights Undervalued Valuation: Trades at a lower EV/EBITDA multiple compared to global and historical averages" [X Link](https://x.com/TLwpstkatlqaks/status/1988405269261643878) 2025-11-12T00:35Z XX followers, XX engagements "#Seegene shows earnings recovery and strong finances yet remains undervalued. Share buyback new products and global expansion may drive a stock rebound pending market trust and legal reforms" [X Link](https://x.com/TLwpstkatlqaks/status/1988410996478931166) 2025-11-12T00:58Z XX followers, XX engagements "The Democratic Party of Korea plans a law mandating treasury stock cancellation within a year. Exceptions apply for stock options. #Seegene holds treasury shares worth 198.6B XXXX% of its total shares likely affected by the new rule" [X Link](https://x.com/TLwpstkatlqaks/status/1988590687840084095) 2025-11-12T12:52Z XX followers, XX engagements "#Seegene unveiled #CURECA the worlds first fully automated PCR platform at ADLM 2025. It enables 24/7 testing eliminates human error and integrates #STAgora for real-time global data analysis to support clinical decisions" [X Link](https://x.com/TLwpstkatlqaks/status/1988612967366349280) 2025-11-12T14:20Z XX followers, XX engagements "#Seegene rebounded in Q3 2025 with strong earnings driven by reagent sales non-respiratory product growth cost efficiency and global expansion. Post-pandemic strategy and new tech mark a pivotal shift toward sustainable global competitiveness" [X Link](https://x.com/TLwpstkatlqaks/status/1988763102306025482) 2025-11-13T00:17Z XX followers, XX engagements "What Will Trigger #Seegenes Next Leap#Seegenes future is stirring great anticipation. What will be the catalyst that propels the company forward With recent innovations like Cureca and strategic shifts in automation and diagnostics many are watching closely for the next" [X Link](https://x.com/TLwpstkatlqaks/status/1988832207083888898) 2025-11-13T04:52Z XX followers, XX engagements "#Seegene is experiencing a recovery in earnings but remains undervalued in the market.Its financials are stableand if the proposed amendment to the Commercial Act mandating treasury share cancellation passesSeegene could benefit as a key stock. Additionally the launch of new" [X Link](https://x.com/TLwpstkatlqaks/status/1988957853139472870) 2025-11-13T13:11Z XX followers, XX engagements "#Seegenea global diagnostics innovatoraims for a disease free world. Partnering with Microsoft it built an AI powered platform enabling rapidcollaborative test kit development. Its cloud based tech boosts R&D speed scalability and global trust through automateddata driven" [X Link](https://x.com/TLwpstkatlqaks/status/1989133122253070672) 2025-11-14T00:47Z XX followers, XX engagements "#Seegene posted a Q3 2025 revenue of KRW 113.5B and operating profit of KRW 9.6B driven by strong non-respiratory syndromic reagent sales. Cost efficiency and new tech like #STAgora and #CURECA boosted profitability and future competitiveness" [X Link](https://x.com/TLwpstkatlqaks/status/1989147296169357431) 2025-11-14T01:44Z XX followers, XX engagements "As of November XX 2025 Seegene's net short selling balance stood at 122208 shares accounting for XXXX% of the company's total outstanding shares of 52225994" [X Link](https://x.com/TLwpstkatlqaks/status/1989225789032923257) 2025-11-14T06:56Z XX followers, XX engagements "#Seegene In Q3 operating profit rose XXXX% to KRW 9.6B net profit surged XXXXX% to KRW 14.6B and sales grew XXX% to KRW 113.5B driven by strong non-COVID diagnostic reagent sales which made up XXXX% of total reagent revenue" [X Link](https://x.com/TLwpstkatlqaks/status/1989306888622883320) 2025-11-14T12:18Z XX followers, XX engagements "#Seegene show strong earnings recovery in2025yet it stock remains undervalued.With a potential law mandating treasury stock cancellationinvestors eye a possible rebound.The firm holds XXXX% in treasury shares and expands its portfolio with new PCR products like Cureca&Stargora" [X Link](https://x.com/TLwpstkatlqaks/status/1990058290865476073) 2025-11-16T14:04Z XX followers, XX engagements "#Cureca #Seegenes fully automated PCR system revolutionizes lab workflows with 24/7 testing and minimized human error. Experts praise its breakthrough in automating even complex stool sample processing redefining diagnostic efficiency and reliability" [X Link](https://x.com/TLwpstkatlqaks/status/1990284053602509211) 2025-11-17T05:01Z XX followers, XX engagements "As of November XX 2025 #Seegene's net short selling balance stood at 121206 shares accounting for XXXX% of the company's total outstanding shares of 52225994" [X Link](https://x.com/TLwpstkatlqaks/status/1990288642099876234) 2025-11-17T05:19Z XX followers, XX engagements "In South Koreas medical device market for Q3 2025 PharmaResearch ranked first with approximately $XXXXX million in revenue while Seegene secured second place with around $XXXXX million achieving a turnaround to profitability driven by growth in nonCOVID diagnostic products" [X Link](https://x.com/TLwpstkatlqaks/status/1990934073368588387) 2025-11-19T00:04Z XX followers, XX engagements "Despite this strong performance Seegenes market capitalization stood at only $XXX million as of November XX compared to PharmaResearchs $XXXX billion. This valuation gap suggests Seegene deserves closer attention" [X Link](https://x.com/TLwpstkatlqaks/status/1990934233947549747) 2025-11-19T00:04Z XX followers, XX engagements "#Seegene is a global leader in molecular diagnostics pioneering syndromic quantitative PCR technology and AI-driven automation. With strategic partnerships like #Microsoft and #SpringerNature Seegene empowers early accurate disease detection worldwide driving innovation" [X Link](https://x.com/TLwpstkatlqaks/status/1989338843754205544) 2025-11-14T14:25Z XX followers, XX engagements "#Seegene shows earnings recovery with strong Q3 results and new products but market skepticism lingers. Share buyback and automation platforms may drive future valuation rebound" [X Link](https://x.com/TLwpstkatlqaks/status/1990215692633923956) 2025-11-17T00:29Z XX followers, XX engagements "#Seegene is a global leader in molecular diagnostics pioneering syndromic quantitative PCR technology and AI-driven automation. With strategic partnerships like #Microsoft and #SpringerNature Seegene empowers early accurate disease detection worldwide driving innovation" [X Link](https://x.com/TLwpstkatlqaks/status/1990218917462306823) 2025-11-17T00:42Z XX followers, XX engagements "The Democratic Party of Korea plans a law mandating treasury stock cancellation within a year. Exceptions apply for stock options. #Seegene holds treasury shares worth 198.6B XXXX% of its total shares likely affected by the new rule" [X Link](https://x.com/TLwpstkatlqaks/status/1990296328447103289) 2025-11-17T05:49Z XX followers, XX engagements "Hoffman Agency Korea won three top honors at the 33rd Korea PR Awards including for its global PR campaign for #Seegene. The campaign effectively communicated Seegenes molecular diagnostics technology to global markets enhancing its international brand positioning" [X Link](https://x.com/TLwpstkatlqaks/status/1990388598479167890) 2025-11-17T11:56Z XX followers, XX engagements "#Seegene joined #Brazils FIS Week 2025 advancing healthcare equity via tech local production and public health partnerships marking a strategic move in its global diagnostics expansion" [X Link](https://x.com/TLwpstkatlqaks/status/1990428461253472350) 2025-11-17T14:35Z XX followers, XX engagements "#Seegene leads molecular diagnostics automation with #CURECA and #STAgora sharing core PCR technologies globally to expand access and efficiency driven by its vision of a disease-free world" [X Link](https://x.com/TLwpstkatlqaks/status/1990449554605687172) 2025-11-17T15:58Z XX followers, XX engagements "#Cureca #Seegenes fully automated PCR system revolutionizes lab workflows with 24/7 testing and minimized human error. Experts praise its breakthrough in automating even complex stool sample processing redefining diagnostic efficiency and reliabilit" [X Link](https://x.com/TLwpstkatlqaks/status/1990577842414104655) 2025-11-18T00:28Z XX followers, XX engagements "#Seegene leads molecular diagnostics by pioneering syndromic quantitative PCR technology and AI-driven automation. Through strategic partnerships with #Microsoft and #SpringerNature it enables early and precise disease detection shaping the future of diagnostic innovation" [X Link](https://x.com/TLwpstkatlqaks/status/1990583516506259923) 2025-11-18T00:51Z XX followers, XX engagements "#Seegene our Bronze Sponsor was honored with a special award at #LIFE2025 for their vital support and commitment to advancing lab medicine and healthcare innovation contributing significantly to collaboration learning and innovation throughout the event" [X Link](https://x.com/TLwpstkatlqaks/status/1990639636247716136) 2025-11-18T04:34Z XX followers, XX engagements "In Q3 2025 #Seegene ranked 2nd in South Koreas medical device market with $174.4M revenue and returned to profit via non-COVID diagnostics. Yet its $910M market cap lags far behind PharmaResearchs $3.22B highlighting a potential undervaluation" [X Link](https://x.com/TLwpstkatlqaks/status/1990933655695601981) 2025-11-19T00:02Z XX followers, XX engagements "As of November XX 2025 #Seegene's net short selling balance stood at 94045 shares accounting for XXXX% of the company's total outstanding shares of 52225994" [X Link](https://x.com/TLwpstkatlqaks/status/1991160795242086561) 2025-11-19T15:05Z XX followers, XX engagements "On March XX 2024 #Seegene CEO Chun Jong-yoon met #UKHSA Chief Jenny Harries in Seoul to discuss global disease prevention. Harries praised Seegenes pandemic response and showed interest in its AI-driven technology-sharing initiative aimed at developing tailored diagnostics" [X Link](https://x.com/TLwpstkatlqaks/status/1991530215047328258) 2025-11-20T15:32Z XX followers, XX engagements "As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1991753304079241252) 2025-11-21T06:19Z XX followers, XX engagements "#Seegene Medical Foundation launched a CLIA-certified diagnostic center in Gardena California marking its U.S. entry. Subsidiary OpenHealthcare introduced the AllrangeKit self-test service and blood collection sites while partnering with Microsoft Azure AI to build a digital" [X Link](https://x.com/TLwpstkatlqaks/status/1992752848338370867) 2025-11-24T00:31Z XX followers, XX engagements "#Seegene is a global leader in molecular diagnostics pioneering syndromic quantitative PCR technology and AI-driven automation. With strategic partnerships like #Microsoft and #SpringerNature Seegene empowers early accurate disease detection worldwide driving innovation" [X Link](https://x.com/TLwpstkatlqaks/status/1992782828552196132) 2025-11-24T02:30Z XX followers, XX engagements "As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 70077 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1992807923760931195) 2025-11-24T04:10Z XX followers, XX engagements "What Is #Seegene's Debt The chart below which you can click on for greater detail shows that #Seegene had 76.8b in debt in June 2025; about the same as the year before. However its balance sheet shows it holds 544.2b in cash so it actually has 467.4b net cash" [X Link](https://x.com/TLwpstkatlqaks/status/1993290870993699126) 2025-11-25T12:09Z XX followers, XX engagements "we can see that #Seegene had liabilities of 161.9b due within XX months and liabilities of 56.8b due beyond that. On the other hand it had cash of 544.2b and 95.7b worth of receivables due within a year. So it can boast 421.2b more liquid assets than total liabilities" [X Link](https://x.com/TLwpstkatlqaks/status/1993313598257741935) 2025-11-25T13:39Z XX followers, XX engagements "liquidity is a great indication that #Seegene's balance sheet is almost as strong as Fort Knox.On this view lenders should feel as safe as the beloved of a black-belt karate master. Seegene has more cash than debt is arguably a good indication that it can manage its debt safely" [X Link](https://x.com/TLwpstkatlqaks/status/1993492372857274721) 2025-11-26T01:29Z XX followers, XX engagements "As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1993510446071267713) 2025-11-26T02:41Z XX followers, XX engagements "#Seegene shows strong financial health converting EBIT into even higher free cash flow last year. This robust cash generation enhances debt management capacity and reassures shareholders with solid performance" [X Link](https://x.com/TLwpstkatlqaks/status/1993545495231545745) 2025-11-26T05:00Z XX followers, XX engagements "#Seegene holds treasury shares worth XXXXX billion KRW XXXX% of issued stock. If mandated cancellation occurs it will signal a firm commitment to restructuring and greater transparency in corporate governance" [X Link](https://x.com/TLwpstkatlqaks/status/1994219274701844664) 2025-11-28T01:38Z XX followers, XX engagements "As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1995162843738784096) 2025-11-30T16:07Z XX followers, XX engagements "As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1995660480376160385) 2025-12-02T01:05Z XX followers, XX engagements "As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1996040185520525410) 2025-12-03T02:13Z XX followers, XX engagements "#Seegenes French subsidiary marks a shift to global localization completing its European JV network with Israel and Spain. Frances regulatory weight boosts standardization of diagnostics while full control in Canada strengthens governance. Seegene pursues localization" [X Link](https://x.com/TLwpstkatlqaks/status/1996227983162622081) 2025-12-03T14:40Z XX followers, XX engagements "As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1996231178534470101) 2025-12-03T14:52Z XX followers, XX engagements "#Seegene partnered with Germanys Epitype to integrate epigenetic biomarker test ScreenYu Gyn into its multiplex PCR portfolio aiming to advance cervical cancer early detection boost patient recovery reduce costs and expand global diagnostic reach" [X Link](https://x.com/TLwpstkatlqaks/status/1996391271993372784) 2025-12-04T01:29Z XX followers, XX engagements "#Seegene has established SEEGENE FRANCE to expand into Western Europe aiming to supply diagnostic reagents and equipment optimized for IVDR compliance and strengthen local networks. The company also launched JVs in Israel and Spain in 2025 while Seegene Canada became a wholly" [X Link](https://x.com/TLwpstkatlqaks/status/1996574974866538771) 2025-12-04T13:39Z XX followers, XX engagements "while Seegene Canada became a wholly owned subsidiary after a minority shareholder exercised a put option" [X Link](https://x.com/TLwpstkatlqaks/status/1996575759272734915) 2025-12-04T13:42Z XX followers, XX engagements "As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1996746983181300027) 2025-12-05T01:02Z XX followers, XX engagements "#Seegene Mexico partners with Canadas #Microbix to embed QAPs quality systems into HPV diagnostics boosting accuracy and trust. This strategic move strengthens cervical cancer prevention accelerates lab validation and positions Seegene to expand across Latin America" [X Link](https://x.com/TLwpstkatlqaks/status/1996847611895250981) 2025-12-05T07:42Z XX followers, XX engagements "As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 70893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1997832625286001073) 2025-12-08T00:56Z XX followers, XX engagements "#KOSDAQ-listed #Seegene posted strong Q3 2025 results showing robust growth and profitability. Operating profit surged XXXX% year-over-year to KRW XXX billion while net profit skyrocketed XXXXX% to KRW XXXX billion. Revenue rose XXX% to KRW XXXXX billion" [X Link](https://x.com/TLwpstkatlqaks/status/1987671413336232272) 2025-11-09T23:59Z XX followers, XX engagements "#Seegenes multiplex PCR enables precise HPV genotyping boosting cervical cancer prevention. Its global role and self-sampling tech improve access advancing WHOs 2030 goal for womens health equity" [X Link](https://x.com/TLwpstkatlqaks/status/1990574679967608853) 2025-11-18T00:16Z XX followers, XX engagements "#Seegene is revolutionizing molecular diagnostics with syndromic quantitative PCR and AI-powered automation. Strategic alliances with #Microsoft and #SpringerNature drive early accurate disease detection and next-gen diagnostic innovation" [X Link](https://x.com/TLwpstkatlqaks/status/1990674931718500496) 2025-11-18T06:54Z XX followers, XXX engagements "According to the Korea Corporate Reputation Research Institutes big data analysis#Seegene topped Dec 2025 brand reputation among listed life science service firms with JS Link second and Boditech Med third. Overall brand big data rose XXX% from NovSeegenes score grew 15.28%" [X Link](https://x.com/TLwpstkatlqaks/status/1996404215267377270) 2025-12-04T02:20Z XX followers, XX engagements "#Seegene opens its 3rd European hub in France targeting major diagnostics markets. Frances strong demand for STI GI and cancer testing plus a private-driven structure favors rapid supply. The subsidiary will launch #CURECA automation and #STAgora platform growth in Europe" [X Link](https://x.com/TLwpstkatlqaks/status/1996745975176826913) 2025-12-05T00:58Z XX followers, XX engagements "Chun Jong-yoon founder & CEO of #Seegene drives global diagnostics innovation. With a Ph.D. in molecular biology he leads tech-sharing initiatives to expand PCR solutions worldwide" [X Link](https://x.com/TLwpstkatlqaks/status/1998183531189768252) 2025-12-09T00:10Z XX followers, XX engagements "Chun Jong-YoonCEO of #Seegeneearned his Ph.D. in Molecular Biology from the University of Tennessee in 1994. He then continued his academic journey as a postdoctoral researcher at Harvard University and UC Berkeleywhere he immersed himself in worldclass research environments" [X Link](https://x.com/TLwpstkatlqaks/status/1998374043595235426) 2025-12-09T12:47Z XX followers, XX engagements "The remarks of #Seegene CEO Chun Jong-yoon go beyond a simple management message carrying philosophical depth. For example his statement that research and work must be placed on the orbit of habit emphasizes a self-directed attitude toward life" [X Link](https://x.com/TLwpstkatlqaks/status/1998374693955665954) 2025-12-09T12:50Z XX followers, XX engagements "Chun Jong-yoon CEO of #Seegene stated that the 2024 strategic partnership with Microsoft goes beyond a simple technology collaboration serving as a stepping stone for the global expansion of the molecular diagnostics platform" [X Link](https://x.com/TLwpstkatlqaks/status/1998374882833465371) 2025-12-09T12:51Z XX followers, XX engagements "As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 70893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010" [X Link](https://x.com/TLwpstkatlqaks/status/1998549582708658509) 2025-12-10T00:25Z XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@TLwpstkatlqaks ExplosiveRiseExplosiveRise posts on X about strong, microsoft, short interest, ipo the most. They currently have XX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance stocks technology brands currencies countries travel destinations
Social topic influence strong, microsoft #2205, short interest #48, ipo #784, ai, products, ceo, future, realtime, accounting
Top assets mentioned Microsoft Corp. (MSFT)
Top posts by engagements in the last XX hours
"#Seegene posted strong Q3 results with KRW 1135B in revenue and KRW 146B net profit driven by reagent sales and cost efficiency. Non-respiratory products grew steadily and global expansion plus new platforms like #STAgora and #CURECA mark a strategic turning point"
X Link 2025-11-08T14:33Z XX followers, XX engagements
"#Seegene partners with #Microsoft to build a PCR tech-sharing platform using #Azure AI and HPC achieving XX% workforce efficiency and 20x faster analysis. With Microsoft Fabric they aim to expand global collaboration and accelerate innovation across diagnostics"
X Link 2025-11-10T00:55Z XX followers, XX engagements
"#Seegene unveiled #CURECA and #STAgora at LMCE 2025. STAgora aids clinical decisions via real-time PCR data analytics while CURECA automates PCR testing to boost lab efficiency and accuracy"
X Link 2025-11-10T02:09Z XX followers, XX engagements
"Chun Jong-yoon founder of #Seegene blends science and entrepreneurship with global vision and ethical leadership. His company advances molecular diagnostics into daily life expanding globally with AI-driven platforms and pandemic-ready solutions"
X Link 2025-11-10T04:51Z XX followers, XX engagements
"#Seegene led by CEO Chun Jong-yoon aims for a disease-free world through PCR-based diagnostics. By combining #AI #cloud #automation and global tech-sharing it evolves into a #platform firm enabling rapid accurate and accessible testing worldwide"
X Link 2025-11-10T07:02Z XX followers, XX engagements
"#Seegene reduced COVID-19 reliance achieving XX% YoY growth in Q3 2025. Non-COVID non-respiratory diagnostics now lead its portfolio. With AI automation and global expansion success in North America is vital for sustained growth"
X Link 2025-11-11T00:05Z XX followers, XX engagements
"#Seegene Medical Foundation opened its new 35th anniversary headquarters in Seoul featuring the worlds first fully automated PCR platform advanced labs and AI systems. The tower symbolizes Seegenes global vision to lead future diagnostics and healthcare innovation"
X Link 2025-11-11T00:34Z XX followers, XX engagements
"#Seegene and partners developed a rapid multiplex PCR test to detect Asian-type DEL a rare blood variant often misclassified as RhD-negative. With XXX% accuracy and faster results it enhances transfusion safety and has gained global recognition in molecular diagnostics"
X Link 2025-11-11T00:40Z XX followers, XX engagements
"#Seegene & #Microsoft formed a strategic alliance to build global diagnostic ecosystem. By integrating AI and cloud technologiesthey unveiled #CURECA& #STAgora revolutionizing PCR automation and realtime analysis. is evolving into platform company driving faster diagnostics"
X Link 2025-11-11T01:13Z XX followers, XX engagements
"#Seegene partners with #Microsoft and #SpringerNature to globalize its PCR tech via AI-driven automation aiming for a disease-free world and transforming biotech through open innovation and global collaboration"
X Link 2025-11-11T01:50Z XX followers, XX engagements
"#Seegene is evolving into a platform company by sharing its automated diagnostic system globally. Through strategic partnerships with Microsoft and Springer Nature it advances AI-driven automation and fosters open innovation to develop localized diagnostic solutions"
X Link 2025-11-11T02:03Z XX followers, XX engagements
"#Seegene holds 198.6B in treasury shares XXXX% of total stock as strategic assets for M&A and tech-sharing. While this signals proactive investment exceeding XX% may raise concerns among shareholders highlighting the need for transparent utilization plans"
X Link 2025-11-11T02:21Z XX followers, XX engagements
"#Seegene is a global leader in molecular diagnostics pioneering syndromic quantitative PCR technology and AI-driven automation. With strategic partnerships like #Microsoft and #SpringerNature Seegene empowers early accurate disease detection worldwide driving innovation"
X Link 2025-11-11T03:27Z XX followers, XX engagements
"As of November X 2025 #Seegene has a total of 52226000 shares outstanding. The net short-selling balance stands at 122208 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-11-11T12:26Z XX followers, XX engagements
"#Seegene posted Q3 revenue of KRW 113.5B and operating profit of KRW 9.6B up XXXXX% QoQ. Net profit surged to KRW 14.6B. Diagnostic reagents drove XXXX% of sales with strong growth in non-respiratory products. Cost efficiency and product mix boosted profitability"
X Link 2025-11-12T00:04Z XX followers, XX engagements
"As of Nov XX 2025 #Seegene is undervalued at KRW 25500 (EV/EBITDA 7x vs global avg 13x). H1 liquid assets rose to KRW 763.1B cash to KRW 268.8B. Non-current liabilities fell by KRW 5.6B. Retained earnings hit KRW 1.073T showing strong financial stability"
X Link 2025-11-12T00:20Z XX followers, XX engagements
"#Seegene Investment Highlights Undervalued Valuation: Trades at a lower EV/EBITDA multiple compared to global and historical averages"
X Link 2025-11-12T00:35Z XX followers, XX engagements
"#Seegene shows earnings recovery and strong finances yet remains undervalued. Share buyback new products and global expansion may drive a stock rebound pending market trust and legal reforms"
X Link 2025-11-12T00:58Z XX followers, XX engagements
"The Democratic Party of Korea plans a law mandating treasury stock cancellation within a year. Exceptions apply for stock options. #Seegene holds treasury shares worth 198.6B XXXX% of its total shares likely affected by the new rule"
X Link 2025-11-12T12:52Z XX followers, XX engagements
"#Seegene unveiled #CURECA the worlds first fully automated PCR platform at ADLM 2025. It enables 24/7 testing eliminates human error and integrates #STAgora for real-time global data analysis to support clinical decisions"
X Link 2025-11-12T14:20Z XX followers, XX engagements
"#Seegene rebounded in Q3 2025 with strong earnings driven by reagent sales non-respiratory product growth cost efficiency and global expansion. Post-pandemic strategy and new tech mark a pivotal shift toward sustainable global competitiveness"
X Link 2025-11-13T00:17Z XX followers, XX engagements
"What Will Trigger #Seegenes Next Leap#Seegenes future is stirring great anticipation. What will be the catalyst that propels the company forward With recent innovations like Cureca and strategic shifts in automation and diagnostics many are watching closely for the next"
X Link 2025-11-13T04:52Z XX followers, XX engagements
"#Seegene is experiencing a recovery in earnings but remains undervalued in the market.Its financials are stableand if the proposed amendment to the Commercial Act mandating treasury share cancellation passesSeegene could benefit as a key stock. Additionally the launch of new"
X Link 2025-11-13T13:11Z XX followers, XX engagements
"#Seegenea global diagnostics innovatoraims for a disease free world. Partnering with Microsoft it built an AI powered platform enabling rapidcollaborative test kit development. Its cloud based tech boosts R&D speed scalability and global trust through automateddata driven"
X Link 2025-11-14T00:47Z XX followers, XX engagements
"#Seegene posted a Q3 2025 revenue of KRW 113.5B and operating profit of KRW 9.6B driven by strong non-respiratory syndromic reagent sales. Cost efficiency and new tech like #STAgora and #CURECA boosted profitability and future competitiveness"
X Link 2025-11-14T01:44Z XX followers, XX engagements
"As of November XX 2025 Seegene's net short selling balance stood at 122208 shares accounting for XXXX% of the company's total outstanding shares of 52225994"
X Link 2025-11-14T06:56Z XX followers, XX engagements
"#Seegene In Q3 operating profit rose XXXX% to KRW 9.6B net profit surged XXXXX% to KRW 14.6B and sales grew XXX% to KRW 113.5B driven by strong non-COVID diagnostic reagent sales which made up XXXX% of total reagent revenue"
X Link 2025-11-14T12:18Z XX followers, XX engagements
"#Seegene show strong earnings recovery in2025yet it stock remains undervalued.With a potential law mandating treasury stock cancellationinvestors eye a possible rebound.The firm holds XXXX% in treasury shares and expands its portfolio with new PCR products like Cureca&Stargora"
X Link 2025-11-16T14:04Z XX followers, XX engagements
"#Cureca #Seegenes fully automated PCR system revolutionizes lab workflows with 24/7 testing and minimized human error. Experts praise its breakthrough in automating even complex stool sample processing redefining diagnostic efficiency and reliability"
X Link 2025-11-17T05:01Z XX followers, XX engagements
"As of November XX 2025 #Seegene's net short selling balance stood at 121206 shares accounting for XXXX% of the company's total outstanding shares of 52225994"
X Link 2025-11-17T05:19Z XX followers, XX engagements
"In South Koreas medical device market for Q3 2025 PharmaResearch ranked first with approximately $XXXXX million in revenue while Seegene secured second place with around $XXXXX million achieving a turnaround to profitability driven by growth in nonCOVID diagnostic products"
X Link 2025-11-19T00:04Z XX followers, XX engagements
"Despite this strong performance Seegenes market capitalization stood at only $XXX million as of November XX compared to PharmaResearchs $XXXX billion. This valuation gap suggests Seegene deserves closer attention"
X Link 2025-11-19T00:04Z XX followers, XX engagements
"#Seegene is a global leader in molecular diagnostics pioneering syndromic quantitative PCR technology and AI-driven automation. With strategic partnerships like #Microsoft and #SpringerNature Seegene empowers early accurate disease detection worldwide driving innovation"
X Link 2025-11-14T14:25Z XX followers, XX engagements
"#Seegene shows earnings recovery with strong Q3 results and new products but market skepticism lingers. Share buyback and automation platforms may drive future valuation rebound"
X Link 2025-11-17T00:29Z XX followers, XX engagements
"#Seegene is a global leader in molecular diagnostics pioneering syndromic quantitative PCR technology and AI-driven automation. With strategic partnerships like #Microsoft and #SpringerNature Seegene empowers early accurate disease detection worldwide driving innovation"
X Link 2025-11-17T00:42Z XX followers, XX engagements
"The Democratic Party of Korea plans a law mandating treasury stock cancellation within a year. Exceptions apply for stock options. #Seegene holds treasury shares worth 198.6B XXXX% of its total shares likely affected by the new rule"
X Link 2025-11-17T05:49Z XX followers, XX engagements
"Hoffman Agency Korea won three top honors at the 33rd Korea PR Awards including for its global PR campaign for #Seegene. The campaign effectively communicated Seegenes molecular diagnostics technology to global markets enhancing its international brand positioning"
X Link 2025-11-17T11:56Z XX followers, XX engagements
"#Seegene joined #Brazils FIS Week 2025 advancing healthcare equity via tech local production and public health partnerships marking a strategic move in its global diagnostics expansion"
X Link 2025-11-17T14:35Z XX followers, XX engagements
"#Seegene leads molecular diagnostics automation with #CURECA and #STAgora sharing core PCR technologies globally to expand access and efficiency driven by its vision of a disease-free world"
X Link 2025-11-17T15:58Z XX followers, XX engagements
"#Cureca #Seegenes fully automated PCR system revolutionizes lab workflows with 24/7 testing and minimized human error. Experts praise its breakthrough in automating even complex stool sample processing redefining diagnostic efficiency and reliabilit"
X Link 2025-11-18T00:28Z XX followers, XX engagements
"#Seegene leads molecular diagnostics by pioneering syndromic quantitative PCR technology and AI-driven automation. Through strategic partnerships with #Microsoft and #SpringerNature it enables early and precise disease detection shaping the future of diagnostic innovation"
X Link 2025-11-18T00:51Z XX followers, XX engagements
"#Seegene our Bronze Sponsor was honored with a special award at #LIFE2025 for their vital support and commitment to advancing lab medicine and healthcare innovation contributing significantly to collaboration learning and innovation throughout the event"
X Link 2025-11-18T04:34Z XX followers, XX engagements
"In Q3 2025 #Seegene ranked 2nd in South Koreas medical device market with $174.4M revenue and returned to profit via non-COVID diagnostics. Yet its $910M market cap lags far behind PharmaResearchs $3.22B highlighting a potential undervaluation"
X Link 2025-11-19T00:02Z XX followers, XX engagements
"As of November XX 2025 #Seegene's net short selling balance stood at 94045 shares accounting for XXXX% of the company's total outstanding shares of 52225994"
X Link 2025-11-19T15:05Z XX followers, XX engagements
"On March XX 2024 #Seegene CEO Chun Jong-yoon met #UKHSA Chief Jenny Harries in Seoul to discuss global disease prevention. Harries praised Seegenes pandemic response and showed interest in its AI-driven technology-sharing initiative aimed at developing tailored diagnostics"
X Link 2025-11-20T15:32Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-11-21T06:19Z XX followers, XX engagements
"#Seegene Medical Foundation launched a CLIA-certified diagnostic center in Gardena California marking its U.S. entry. Subsidiary OpenHealthcare introduced the AllrangeKit self-test service and blood collection sites while partnering with Microsoft Azure AI to build a digital"
X Link 2025-11-24T00:31Z XX followers, XX engagements
"#Seegene is a global leader in molecular diagnostics pioneering syndromic quantitative PCR technology and AI-driven automation. With strategic partnerships like #Microsoft and #SpringerNature Seegene empowers early accurate disease detection worldwide driving innovation"
X Link 2025-11-24T02:30Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 70077 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-11-24T04:10Z XX followers, XX engagements
"What Is #Seegene's Debt The chart below which you can click on for greater detail shows that #Seegene had 76.8b in debt in June 2025; about the same as the year before. However its balance sheet shows it holds 544.2b in cash so it actually has 467.4b net cash"
X Link 2025-11-25T12:09Z XX followers, XX engagements
"we can see that #Seegene had liabilities of 161.9b due within XX months and liabilities of 56.8b due beyond that. On the other hand it had cash of 544.2b and 95.7b worth of receivables due within a year. So it can boast 421.2b more liquid assets than total liabilities"
X Link 2025-11-25T13:39Z XX followers, XX engagements
"liquidity is a great indication that #Seegene's balance sheet is almost as strong as Fort Knox.On this view lenders should feel as safe as the beloved of a black-belt karate master. Seegene has more cash than debt is arguably a good indication that it can manage its debt safely"
X Link 2025-11-26T01:29Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-11-26T02:41Z XX followers, XX engagements
"#Seegene shows strong financial health converting EBIT into even higher free cash flow last year. This robust cash generation enhances debt management capacity and reassures shareholders with solid performance"
X Link 2025-11-26T05:00Z XX followers, XX engagements
"#Seegene holds treasury shares worth XXXXX billion KRW XXXX% of issued stock. If mandated cancellation occurs it will signal a firm commitment to restructuring and greater transparency in corporate governance"
X Link 2025-11-28T01:38Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-11-30T16:07Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-02T01:05Z XX followers, XX engagements
"As of November XX 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-03T02:13Z XX followers, XX engagements
"#Seegenes French subsidiary marks a shift to global localization completing its European JV network with Israel and Spain. Frances regulatory weight boosts standardization of diagnostics while full control in Canada strengthens governance. Seegene pursues localization"
X Link 2025-12-03T14:40Z XX followers, XX engagements
"As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-03T14:52Z XX followers, XX engagements
"#Seegene partnered with Germanys Epitype to integrate epigenetic biomarker test ScreenYu Gyn into its multiplex PCR portfolio aiming to advance cervical cancer early detection boost patient recovery reduce costs and expand global diagnostic reach"
X Link 2025-12-04T01:29Z XX followers, XX engagements
"#Seegene has established SEEGENE FRANCE to expand into Western Europe aiming to supply diagnostic reagents and equipment optimized for IVDR compliance and strengthen local networks. The company also launched JVs in Israel and Spain in 2025 while Seegene Canada became a wholly"
X Link 2025-12-04T13:39Z XX followers, XX engagements
"while Seegene Canada became a wholly owned subsidiary after a minority shareholder exercised a put option"
X Link 2025-12-04T13:42Z XX followers, XX engagements
"As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 58893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-05T01:02Z XX followers, XX engagements
"#Seegene Mexico partners with Canadas #Microbix to embed QAPs quality systems into HPV diagnostics boosting accuracy and trust. This strategic move strengthens cervical cancer prevention accelerates lab validation and positions Seegene to expand across Latin America"
X Link 2025-12-05T07:42Z XX followers, XX engagements
"As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 70893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-08T00:56Z XX followers, XX engagements
"#KOSDAQ-listed #Seegene posted strong Q3 2025 results showing robust growth and profitability. Operating profit surged XXXX% year-over-year to KRW XXX billion while net profit skyrocketed XXXXX% to KRW XXXX billion. Revenue rose XXX% to KRW XXXXX billion"
X Link 2025-11-09T23:59Z XX followers, XX engagements
"#Seegenes multiplex PCR enables precise HPV genotyping boosting cervical cancer prevention. Its global role and self-sampling tech improve access advancing WHOs 2030 goal for womens health equity"
X Link 2025-11-18T00:16Z XX followers, XX engagements
"#Seegene is revolutionizing molecular diagnostics with syndromic quantitative PCR and AI-powered automation. Strategic alliances with #Microsoft and #SpringerNature drive early accurate disease detection and next-gen diagnostic innovation"
X Link 2025-11-18T06:54Z XX followers, XXX engagements
"According to the Korea Corporate Reputation Research Institutes big data analysis#Seegene topped Dec 2025 brand reputation among listed life science service firms with JS Link second and Boditech Med third. Overall brand big data rose XXX% from NovSeegenes score grew 15.28%"
X Link 2025-12-04T02:20Z XX followers, XX engagements
"#Seegene opens its 3rd European hub in France targeting major diagnostics markets. Frances strong demand for STI GI and cancer testing plus a private-driven structure favors rapid supply. The subsidiary will launch #CURECA automation and #STAgora platform growth in Europe"
X Link 2025-12-05T00:58Z XX followers, XX engagements
"Chun Jong-yoon founder & CEO of #Seegene drives global diagnostics innovation. With a Ph.D. in molecular biology he leads tech-sharing initiatives to expand PCR solutions worldwide"
X Link 2025-12-09T00:10Z XX followers, XX engagements
"Chun Jong-YoonCEO of #Seegeneearned his Ph.D. in Molecular Biology from the University of Tennessee in 1994. He then continued his academic journey as a postdoctoral researcher at Harvard University and UC Berkeleywhere he immersed himself in worldclass research environments"
X Link 2025-12-09T12:47Z XX followers, XX engagements
"The remarks of #Seegene CEO Chun Jong-yoon go beyond a simple management message carrying philosophical depth. For example his statement that research and work must be placed on the orbit of habit emphasizes a self-directed attitude toward life"
X Link 2025-12-09T12:50Z XX followers, XX engagements
"Chun Jong-yoon CEO of #Seegene stated that the 2024 strategic partnership with Microsoft goes beyond a simple technology collaboration serving as a stepping stone for the global expansion of the molecular diagnostics platform"
X Link 2025-12-09T12:51Z XX followers, XX engagements
"As of December X 2025 #Seegene has a total of 52225994 shares outstanding. The net short-selling balance stands at 70893 shares representing just XXXX% of the total. This marks the lowest short interest since the companys IPO in 2010"
X Link 2025-12-10T00:25Z XX followers, XX engagements
/creator/twitter::TLwpstkatlqaks